Catalyst Funds Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDLN
Medline Inc
MDLN
|
+$11.5M |
| 2 |
Arm
ARM
|
+$10.9M |
| 3 |
AstraZeneca
AZN
|
+$10M |
| 4 |
Cisco
CSCO
|
+$8.29M |
| 5 |
AbbVie
ABBV
|
+$7.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$24.5M |
| 2 |
NVIDIA
NVDA
|
+$16.4M |
| 3 |
Revolution Medicines
RVMD
|
+$15.9M |
| 4 |
Rio Tinto
RIO
|
+$11.5M |
| 5 |
Walmart Inc
WMT
|
+$9.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.62% |
| 2 | Industrials | 14.98% |
| 3 | Healthcare | 13.14% |
| 4 | Financials | 10.95% |
| 5 | Materials | 9.35% |
No holdings matched the selected filter criteria.
Similar funds
Catalyst Funds Management's Q1 2026 Portfolio in Review
As of Q1 2026, Catalyst Funds Management held 732 positions worth $591M, up 37% from $431M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Catalyst Funds Management deployed $155M of net new capital in Q1 2026, opening 402 new positions and adding to 110 existing holdings. Its largest new stake was Medline Inc: 259,595 shares worth $11.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Broadcom, an estimated $24.5M trimmed.
- Catalyst Funds Management's largest Q1 2026 buy was Medline Inc: 259,595 shares worth $11.6M.
- Catalyst Funds Management added most to AstraZeneca in Q1 2026, an estimated $10M increase.
- Catalyst Funds Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $24.5M.
- Catalyst Funds Management fully exited News Corp Class B in Q1 2026, selling an estimated $5.22M.
- Catalyst Funds Management's ten largest holdings make up 18% of its $591M portfolio in Q1 2026.
- Catalyst Funds Management opened 402 new positions and closed 148 in Q1 2026.
- Catalyst Funds Management's portfolio value rose 37% quarter-over-quarter to $591M.
Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.